Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7216
Delayed Data
As of 10:36am ET
 -0.0134 / -1.82%
Today’s Change
0.65
Today|||52-Week Range
1.29
+3.09%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.74
Today’s open0.73
Day’s range0.72 - 0.74
Volume39,388
Average volume (3 months)948,212
Market cap$131.7M
Dividend yield--
Data as of 10:36am ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc+0.17+8.10%
NERVMinerva Neuroscience...-0.07-1.32%
MRNSMarinus Pharmaceutic...+0.03+0.33%
BLPHBellerophon Therapeu...-0.25-2.50%
Data as of 10:52am ET, 03/30/2015

Financials

Next reporting dateMay 14, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account